首页 > 最新文献

Journal of Parenteral and Enteral Nutrition最新文献

英文 中文
Parenteral nutrition and bioelectrical impedance analysis estimated fat-free mass in adult patients with chronic intestinal failure: A descriptive cohort study 肠外营养和生物电阻抗分析估计慢性肠功能衰竭成年患者的去脂质量:一项描述性队列研究。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-20 DOI: 10.1002/jpen.2752
Trevor Tabone MD
{"title":"Parenteral nutrition and bioelectrical impedance analysis estimated fat-free mass in adult patients with chronic intestinal failure: A descriptive cohort study","authors":"Trevor Tabone MD","doi":"10.1002/jpen.2752","DOIUrl":"10.1002/jpen.2752","url":null,"abstract":"","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 5","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143670285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between a 6-h feeding protocol and postprocedure hospital length of stay following percutaneous endoscopic gastrostomy in hospitalized adults: A before-and-after cohort study 住院成人经皮内镜胃造口术后6小时喂养方案与术后住院时间的关系:一项前后队列研究
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2751
Trevor Tabone MD
{"title":"Association between a 6-h feeding protocol and postprocedure hospital length of stay following percutaneous endoscopic gastrostomy in hospitalized adults: A before-and-after cohort study","authors":"Trevor Tabone MD","doi":"10.1002/jpen.2751","DOIUrl":"10.1002/jpen.2751","url":null,"abstract":"","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 4","pages":"402-403"},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143657558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition and Metabolism Research Oral Paper Session Abstracts 营养与代谢研究口头报告会议摘要。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2733
<p><b>Sunday, March 23, 2025</b></p><p><b>SU30 Parenteral Nutrition Therapy</b></p><p><b>SU31 Enteral Nutrition Therapy</b></p><p><b>SU32 Malnutrition and Nutrition Assessment</b></p><p><b>SU33 Critical Care and Critical Health Issues</b></p><p><b>SU34 GI, Obesity, Metabolic, and Other Nutrition Related Concepts</b></p><p><b>SU35 Pediatric, Neonatal, Pregnancy, and Lactation</b></p><p><b>Parenteral Nutrition Therapy</b></p><p><b>Abstract of Distinction</b></p><p>Shaurya Mehta, BS<sup>1</sup>; Chandrashekhara Manithody, PhD<sup>1</sup>; Arun Verma, MD<sup>1</sup>; Christine Denton<sup>1</sup>; Kento Kurashima, MD, PhD<sup>1</sup>; Jordyn Wray<sup>1</sup>; Ashlesha Bagwe, MD<sup>1</sup>; Sree Kolli<sup>1</sup>; Marzena Swiderska-Syn<sup>1</sup>; Miguel Guzman, MD<sup>1</sup>; Sherri Besmer, MD<sup>1</sup>; Sonali Jain, MD<sup>1</sup>; Matthew Mchale, MD<sup>1</sup>; John Long, DVM<sup>1</sup>; Chelsea Hutchinson, MD<sup>1</sup>; Aaron Ericsson, DVM, PhD<sup>2</sup>; Ajay Jain, MD, DNB, MHA<sup>1</sup></p><p><sup>1</sup>Saint Louis University, St. Louis, MO; <sup>2</sup>University of Missouri, Columbia, MO</p><p><b>Financial Support:</b> None Reported.</p><p><b>Background:</b> Total parenteral nutrition (TPN) provides lifesaving nutritional support intravenously, however, is associated with significant side effects. Given gut microbial alterations noted with TPN, we hypothesized transferring intestinal microbiota from healthy controls to those on TPN would restore gut-systemic signaling and mitigate injury.</p><p><b>Methods:</b> Using our novel ambulatory model (US Provisional Patent: US 63/136,165), 31 piglets were randomly allocated to enteral nutrition (EN), TPN only, TPN + antibiotics (TPN-A) or TPN + post pyloric intestinal microbiota transplant (TPN-IMT) for 14 days. Gut, liver, and serum samples were assessed though histology, biochemistry, and qPCR. Stool samples underwent 16s rRNA sequencing. PERMANOVA, Jaccard and Bray-Curtis metrics were performed.</p><p><b>Results:</b> Significant bilirubin elevation in TPN and TPN-A vs EN (p < 0.0001) was prevented with IMT. Serum cytokine profiles revealed significantly higher IFN-G, TNF-alpha, IL-beta, IL-8, in TPN (p = 0.009/0.001/0.043/0.011), with preservation upon IMT. Significant gut-atrophy by villous/crypt ratio in TPN (p < 0.0001) and TPN-A (p = 0.0001) vs EN was prevented by IMT (p = 0.426 vs EN). Microbiota profiles using Principal Coordinate Analysis (PCA) demonstrated significant overlap between IMT and EN, with the largest separation in TPN-A followed by TPN, driven primarily by firmicutes and fusobacteria. TPN altered gut barrier (Claudin-3 and Occludin) was preserved upon IMT. Gene expression showed upregulation of CYP7A1 and BSEP in TPN and TPN-A, with downregulation of FGFR4, EGF, FXR and TGR5 vs EN and prevention with IMT. In a subgroup analysis on TPN and EN, regional gut integrity differences were analyzed through the varying presence of E-cadherin and Occludin in the segment
su30肠外营养治疗su31肠内营养治疗su32营养不良和营养评估su33重症监护和关键健康问题su34 GI,肥胖,代谢和其他营养相关概念su35儿科,新生儿,妊娠和哺乳期肠外营养治疗钱德拉谢哈拉哲学博士;阿伦·维尔马,MD1;克里斯汀Denton1;仓岛健人,MD, phd;Jordyn Wray1;Ashlesha Bagwe, MD1;Sree Kolli1;Marzena Swiderska-Syn1;米格尔·古兹曼,MD1;Sherri Besmer, MD1;Sonali Jain, MD1;马修·麦克海尔,MD1;约翰·朗,DVM1;切尔西·哈钦森,MD1;Aaron Ericsson, DVM, PhD2;Ajay Jain, MD, DNB, mha11圣路易斯大学,圣路易斯,密苏里州;2 .密苏里大学哥伦比亚分校,momo。资金支持:无报道。背景:全肠外营养(TPN)提供了挽救生命的静脉营养支持,然而,与显著的副作用相关。考虑到TPN引起的肠道微生物改变,我们假设将肠道微生物群从健康对照组转移到TPN组可以恢复肠道系统信号并减轻损伤。方法:采用我们的新型动态模型(美国临时专利:US 63/136,165),将31头仔猪随机分为肠内营养(EN)、TPN +抗生素(TPN- a)或TPN +幽门后肠道微生物群移植(TPN- imt),为期14天。通过组织学、生物化学和qPCR对肠道、肝脏和血清样本进行评估。粪便样本进行16s rRNA测序。采用PERMANOVA、Jaccard和Bray-Curtis指标。结果:IMT可预防TPN和TPN- a vs EN的显著胆红素升高(p &lt; 0.0001)。血清细胞因子谱显示,TPN组IFN-G、tnf - α、il - β、IL-8显著升高(p = 0.009/0.001/0.043/0.011), IMT后保存。在TPN (p &lt; 0.0001)和TPN- a (p = 0.0001)与EN相比,IMT可以防止绒毛/隐窝比显著的肠道萎缩(p = 0.426 vs EN)。主坐标分析(PCA)显示IMT和EN之间存在显著的微生物群重叠,TPN- a中最大的分离,其次是TPN,主要由厚壁菌门和梭杆菌驱动。TPN改变的肠屏障(Claudin-3和Occludin)在IMT后被保留。基因表达显示,TPN和TPN- a中CYP7A1和BSEP上调,FGFR4、EGF、FXR和TGR5相对EN下调,IMT预防。在TPN和EN的亚组分析中,通过近端肠、远端肠和结肠中E-cadherin和Occludin的不同存在,分析了区域肠道完整性差异。与EN组相比,TPN组E-Cadherin和Occludin水平显著降低。结论:本研究为幽门后IMT预防肠道萎缩、肝损伤、肠道屏障功能障碍和微生物生态失调提供了新的证据,挑战了目前关于TPN损伤机制的范式,并进一步强调了肠道微生物作为治疗和药物发现的主要靶点的重要性。Dejan Micic, MD1;Ena Muhic, MD2;Samuel Kocoshis, MD3;洛里斯·皮罗尼,MD4;Simon Lal,医学博士,FRCP5;法鲁克·拉赫曼,MD6;Alan Buchman, MD, MSPH7;Jacqueline Zummo,博士,MBA, MPH8;Khushboo Belani, MPH8;埃皮·布朗,注册会计师,MA8;麦肯纳·梅特卡夫,BA8;Andrea DiFiglia, MS8;Palle Jeppesen, MD, PhD9;Jenny Han, ms101芝加哥大学,芝加哥,伊利诺伊州;2丹麦哥本哈根rigshospitalet;辛辛那提儿童医院医疗中心,俄亥俄州辛辛那提;4意大利博洛尼亚大学,博洛尼亚,艾米利亚-罗马涅;5索尔福德皇家国民保健服务基金会信托基金,英格兰索尔福德;6伦敦大学学院,英国伦敦;7伊利诺伊大学芝加哥分校,格兰科,伊利诺伊州;8Protara Therapeutics,纽约;9丹麦,哥本哈根,Hovedstaden, Rigshospitalet,肠衰竭和肝病科;10 . pharmacace是无锡药明康德(Wuxi AppTec)的子公司,资金支持:Protara Therapeutics。背景:胆碱是一种季胺,是人体必需的膳食营养素。它对于依赖肠外支持(PS)的肠衰竭(IF)患者至关重要,因为缺乏可导致肝损伤、神经心理障碍、肌肉损伤和血栓形成异常。目前,全球还没有批准用于PS患者的静脉注射胆碱产品。方法:THRIVE-1是一项前瞻性、多中心、横断面、观察性研究,旨在评估依赖PS的青少年(≥12岁)和成年IF患者(≥18岁)胆碱缺乏和肝损伤的患病率;(定义为在10至24周(上限为25%)或24周或更长时间内,每周最少4天领取私人护理津贴)。数据收集发生在一次诊所访问期间。结果:78例入组患者中,55%为男性,92%为白人,96%为非西班牙裔或拉丁裔。平均年龄52岁(SD: 16.6), BMI为23.0 kg/m2 (SD: 3.8;表1)。 年龄范围为21-64岁,平均基线bmi为26-40。在这61项研究中,纤维补充的特点是使用益生元纤维(n = 33)或其他膳食纤维(n = 28),其中8项研究与益生菌补充联合进行。最常用的干预措施是含有菊粉型果聚糖(即菊粉和低聚果糖)的纤维,其次是β -葡聚糖。干预时间为4-52周。在54%的研究(n = 33)中,体重减轻与统计学上显著的变化相关。41项研究报告了身体成分,发现纤维补充与腰围(n = 19项研究)、内脏脂肪(n = 6)、脂肪量(n = 16)和瘦体重(n = 5)的变化有关。据报道,在饱腹感测量(n = 7)、血糖和胰岛素参数(n = 14)以及微生物群落(n = 8)方面也发生了统计学上显著的变化。结论:本系统综述的结果支持使用纤维补充剂作为辅助策略来支持超重/肥胖成人的体重管理。旨在增加BMI升高的成年人纤维摄入量的干预措施可能会改善身体成分,对健康有益。Radha Chada博士,RD1;Jaini Paresh Gala, MS2;Ashwini Chandrasekaran, MSc1;Monish Karunakaran, MS, DrNB1;饶国伟,MS, MAMS, FRCS3;普拉迪普·雷巴拉,MS1;Balakrishna Nagalla,博士41亚洲胃肠病学研究所,泰伦加纳邦海得拉巴;2印度泰伦加纳邦海得拉巴亚洲胃肠病研究所;3泰伦加纳邦海得拉巴亚洲胃肠病学研究所;4阿波罗医院教育和研究基金会,海德拉巴,泰伦甘纳邦。背景:肌肉减少症一直被认为是慢性疾病的预后因素,并且由于肌肉质量和功能减少,与癌症患者死亡率增加有关。本研究旨在评估胰腺癌行胰十二指肠切除术患者肌肉减少症的诊断及其对术后预后的影响。方法:采用亚洲性别特异性肌肉减少症标准,对总骨骼肌面积(SMA)、腹部计算机断层扫描(CT)得出的总骨骼肌指数(SMI)和握力(HGS)进行量化。分析肌肉减少症和6分钟步行距离(6-MWD)对术后住院时间(LOS)和死亡率的影响。结果:共122例患
{"title":"Nutrition and Metabolism Research Oral Paper Session Abstracts","authors":"","doi":"10.1002/jpen.2733","DOIUrl":"10.1002/jpen.2733","url":null,"abstract":"&lt;p&gt;&lt;b&gt;Sunday, March 23, 2025&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU30 Parenteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU31 Enteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU32 Malnutrition and Nutrition Assessment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU33 Critical Care and Critical Health Issues&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU34 GI, Obesity, Metabolic, and Other Nutrition Related Concepts&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;SU35 Pediatric, Neonatal, Pregnancy, and Lactation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Parenteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Abstract of Distinction&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Shaurya Mehta, BS&lt;sup&gt;1&lt;/sup&gt;; Chandrashekhara Manithody, PhD&lt;sup&gt;1&lt;/sup&gt;; Arun Verma, MD&lt;sup&gt;1&lt;/sup&gt;; Christine Denton&lt;sup&gt;1&lt;/sup&gt;; Kento Kurashima, MD, PhD&lt;sup&gt;1&lt;/sup&gt;; Jordyn Wray&lt;sup&gt;1&lt;/sup&gt;; Ashlesha Bagwe, MD&lt;sup&gt;1&lt;/sup&gt;; Sree Kolli&lt;sup&gt;1&lt;/sup&gt;; Marzena Swiderska-Syn&lt;sup&gt;1&lt;/sup&gt;; Miguel Guzman, MD&lt;sup&gt;1&lt;/sup&gt;; Sherri Besmer, MD&lt;sup&gt;1&lt;/sup&gt;; Sonali Jain, MD&lt;sup&gt;1&lt;/sup&gt;; Matthew Mchale, MD&lt;sup&gt;1&lt;/sup&gt;; John Long, DVM&lt;sup&gt;1&lt;/sup&gt;; Chelsea Hutchinson, MD&lt;sup&gt;1&lt;/sup&gt;; Aaron Ericsson, DVM, PhD&lt;sup&gt;2&lt;/sup&gt;; Ajay Jain, MD, DNB, MHA&lt;sup&gt;1&lt;/sup&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Saint Louis University, St. Louis, MO; &lt;sup&gt;2&lt;/sup&gt;University of Missouri, Columbia, MO&lt;/p&gt;&lt;p&gt;&lt;b&gt;Financial Support:&lt;/b&gt; None Reported.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Total parenteral nutrition (TPN) provides lifesaving nutritional support intravenously, however, is associated with significant side effects. Given gut microbial alterations noted with TPN, we hypothesized transferring intestinal microbiota from healthy controls to those on TPN would restore gut-systemic signaling and mitigate injury.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Methods:&lt;/b&gt; Using our novel ambulatory model (US Provisional Patent: US 63/136,165), 31 piglets were randomly allocated to enteral nutrition (EN), TPN only, TPN + antibiotics (TPN-A) or TPN + post pyloric intestinal microbiota transplant (TPN-IMT) for 14 days. Gut, liver, and serum samples were assessed though histology, biochemistry, and qPCR. Stool samples underwent 16s rRNA sequencing. PERMANOVA, Jaccard and Bray-Curtis metrics were performed.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results:&lt;/b&gt; Significant bilirubin elevation in TPN and TPN-A vs EN (p &lt; 0.0001) was prevented with IMT. Serum cytokine profiles revealed significantly higher IFN-G, TNF-alpha, IL-beta, IL-8, in TPN (p = 0.009/0.001/0.043/0.011), with preservation upon IMT. Significant gut-atrophy by villous/crypt ratio in TPN (p &lt; 0.0001) and TPN-A (p = 0.0001) vs EN was prevented by IMT (p = 0.426 vs EN). Microbiota profiles using Principal Coordinate Analysis (PCA) demonstrated significant overlap between IMT and EN, with the largest separation in TPN-A followed by TPN, driven primarily by firmicutes and fusobacteria. TPN altered gut barrier (Claudin-3 and Occludin) was preserved upon IMT. Gene expression showed upregulation of CYP7A1 and BSEP in TPN and TPN-A, with downregulation of FGFR4, EGF, FXR and TGR5 vs EN and prevention with IMT. In a subgroup analysis on TPN and EN, regional gut integrity differences were analyzed through the varying presence of E-cadherin and Occludin in the segment","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 S1","pages":"S5-S80"},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2733","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poster Abstracts 海报摘要。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2735
<p><b>P1–P34 Parenteral Nutrition Therapy</b></p><p><b>P35–P52 Enteral Nutrition Therapy</b></p><p><b>P53–P83 Malnutrition and Nutrition Assessment</b></p><p><b>P84–P103 Critical Care and Critical Health Issues</b></p><p><b>P104–P131 GI, Obesity, Metabolic, and Other Nutrition Related Concepts</b></p><p><b>P132–P165 Pediatric, Neonatal, Pregnancy, and Lactation</b></p><p><b>Parenteral Nutrition Therapy</b></p><p>Sarah Williams, MD, CNSC<sup>1</sup>; Angela Zimmerman, RD, CNSC<sup>2</sup>; Denise Jezerski, RD, CNSC<sup>2</sup>; Ashley Bestgen, RD, CNSC<sup>2</sup></p><p><sup>1</sup>Cleveland Clinic Foundation, Parma, OH; <sup>2</sup>Cleveland Clinic Foundation, Cleveland, OH</p><p><b>Financial Support:</b> Morrison Healthcare.</p><p><b>Background:</b> Essential fatty acid deficiency (EFAD) is a rare disorder among the general population but can be a concern in patients reliant on home parenteral nutrition (HPN), particularly those who are not receiving intravenous lipid emulsions (ILE). In the US, the only ILE available until 2016 was soybean oil based (SO-ILE), which contains more than adequate amounts of essential fatty acids, including alpha-linolenic acid (ALA, an omega-3 fatty acid) and linoleic acid (LA, an omega-6 fatty acid). In 2016, a mixed ILE containing soybean oil, medium chain triglycerides, olive oil and fish oil, became available (SO, MCT, OO, FO-ILE). However, it contains a lower concentration of essential fatty acids compared to SO-ILE, raising theoretical concerns for development of EFAD if not administered in adequate amounts. Liver dysfunction is a common complication in HPN patients that can occur with soybean based ILE use due to their pro-inflammatory properties. Short-term studies and case reports in patients receiving SO, MCT, OO, FO-ILE have shown improvements in liver dysfunction for some patients. Our study evaluates the long-term impact of SO, MCT, OO, FO-ILE in our HPN patient population.</p><p><b>Methods:</b> This single-center, retrospective cohort study was conducted at the Cleveland Clinic Center for Human Nutrition using data from 2017 to 2020. It involved adult patients who received HPN with SO, MCT, OO, FO-ILE for a minimum of one year. The study assessed changes in essential fatty acid profiles, including triene-tetraene ratios (TTRs) and liver function tests (LFTs) over the year. Data was described as mean and standard deviation for normal distributed continuous variables, medians and interquartile range for non-normally distributed continuous variables and frequency for categorical variables. The Wilcoxon signed rank test was used to compare the baseline and follow-up TTR values (mixed time points). The Wilcoxon signed rank test with pairwise comparisons was used to compare the LFTs at different time points and to determine which time groups were different. P-values were adjusted using Bonferroni corrections. Ordinal logistic regression was used to assess the association between lipid dosing and follow-up T
p3 - p34肠外营养治疗p3 - p52肠内营养治疗p3 - p83营养不良和营养评估p3 - p103重症监护和关键健康问题p3 - p131 GI、肥胖、代谢和其他营养相关概念p3 - p165儿科、新生儿、妊娠和哺乳期肠外营养治疗Angela Zimmerman, RD, CNSC2;Denise Jezerski, RD, CNSC2;Ashley Bestgen, RD, cnsc21克利夫兰诊所基金会,帕尔马,俄亥俄州;2克利夫兰诊所基金会,俄亥俄州克利夫兰。背景:必需脂肪酸缺乏症(EFAD)在普通人群中是一种罕见的疾病,但对于依赖家庭肠外营养(HPN)的患者,特别是那些不接受静脉脂质乳(ILE)的患者,可能是一个问题。在美国,直到2016年,唯一可用的ILE是基于大豆油的(SO-ILE),它含有足够量的必需脂肪酸,包括α -亚麻酸(ALA,一种ω -3脂肪酸)和亚油酸(LA,一种ω -6脂肪酸)。2016年,一种含有大豆油、中链甘油三酯、橄榄油和鱼油的混合ILE问世(SO、MCT、OO、FO-ILE)。然而,与SO-ILE相比,它含有较低浓度的必需脂肪酸,如果不给予足够的量,理论上对EFAD的发展提出了担忧。肝功能障碍是HPN患者的常见并发症,由于大豆基ILE的促炎特性,可发生肝功能障碍。短期研究和病例报告显示,接受SO、MCT、OO、FO-ILE的患者肝功能改善。我们的研究评估了SO、MCT、OO、FO-ILE在我们的HPN患者群体中的长期影响。方法:这项单中心、回顾性队列研究在克利夫兰人类营养中心进行,使用了2017年至2020年的数据。该研究涉及接受HPN并接受SO、MCT、OO、FO-ILE至少一年的成年患者。该研究评估了一年来必需脂肪酸谱的变化,包括三烯-四烯比率(trs)和肝功能测试(LFTs)。对于正态分布的连续变量,用平均值和标准差来描述数据;对于非正态分布的连续变量,用中位数和四分位数范围来描述数据;对于分类变量,用频率来描述数据。采用Wilcoxon符号秩检验比较基线和随访的TTR值(混合时间点)。采用两两比较的Wilcoxon符号秩检验来比较不同时间点的LFTs,并确定哪些时间组不同。p值采用Bonferroni校正进行调整。使用有序逻辑回归评估脂质剂量与随访TTR水平之间的关系。采用R软件进行分析,假设所有检验的显著性水平为0.05。结果:在筛选的110例患者中,26例符合基线和随访trs的纳入标准。所有患者均未发生EFAD,基线与随访期间TTR值分布无显著差异。此外,5.5%的患者在接受SO、MCT、OO、FO-ILE时报告了不良的胃肠道症状。另设14例LFTs异常亚组,包括胆红素、碱性磷酸酶(AP)、天冬氨酸转氨酶(AST)或丙氨酸转氨酶(ALT)。AST、ALT改善有统计学意义,胆红素、AP降低无统计学意义。结论:我们发现,使用SO、MCT、OO、FO-ILE作为主要脂质来源的26例患者中,没有任何患者发生EFAD,并且在引入SO、MCT、OO、FO-ILE后,TTRs保持统计学不变。此外,在SO、MCT、OO、FO-ILE开始后,AST和ALT均有统计学意义的降低。虽然PN引起的肝功能障碍是多因素的,但与SO-ILEs相比,使用基于鱼油的脂质已被证明可以改善LFT结果,因为植物甾醇含量减少,促炎ω -6含量减少。一个重要的限制是很难通过门诊环境中的家庭保健护理获得TTR测量,这大大减少了可以分析EFAD的患者数量。表1。26例基线及随访TTR患者描述性统计。表2。与基线水平相比,3个月、6个月、9个月和12个月LFTs的变化。Wendy Raissle, RD, CNSC1;汉娜·韦尔奇,MS, RD2;Jan Nguyen, PharmD31Optum输液药房,七叶树,AZ;2Optum输液药房,凤凰城,亚利桑那州;3Optum Infusion Pharmacy, Mesa, az1。资金支持:无报告。背景:铝是肠外营养液中的一种非营养性污染物。 HPN患者的年患病率和每位患者的平均导管天数(2007 - 2022)。图2。HPN患者年发病率(2007 - 2022)。图3。导管相关血流感染(每1000个导管日发生的事件)。Jill Murphree, MS, RD, CNSC, LDN1;Anne Ammons, RD, LDN, CNSC2;Vanessa Kumpf,药学博士,BCNSP, FASPEN2;道恩·亚当斯,医学博士,硕士,cnsc21田纳西州纳什维尔范德比尔特大学医学中心;2范德比尔特大学医学中心,纳什维尔,田纳西州财政支持:无报告。背景:由于各种因素,确定需要家庭肠外营养(HPN)的患者的宏量营养素目标可能很困难。虽然间接量热法是测量能量消耗的金标准,但它在门诊环境中并不容易获得。因此,临床医生通常依靠不太准确的基于体重的方程式来评估蛋白质和能量需求。能量目标也受到减重、增重或维持体重的目标愿望的影响。接受HPN的患者可能会摄入一些口服膳食,并经历不同程度的宏量营养素吸收。这些因素,以及潜在的临床条件,可以显著影响蛋白质和能量需求,并可能在HPN治疗过程中发生变化。本研究的目的是评估由一家大型学术医疗中心的跨学科肠衰竭诊所管理的接受HPN治疗的患者所规定的蛋白质和能量剂量范围。方法:利用HPN患者数据库,回顾性获取2021年5月至2023年5月期间所有因PN出院的患者的患者人口统计数据,包括患者年龄、性别和PN指征/诊断。 在HPN开始时、出院后2周、2至3个月和6个月的间隔从电子病历中提取额外信息,包括身高、实际体重、目标体重、HPN能量剂量、HPN蛋白剂量以及患者是否进食。数据收集在HPN治疗完成或HPN治疗6个月后结束。所有数据都输入并储存在电子数据库中。结果:在研究期间,248例患者开始接受HPN治疗,其中56例患者接受HPN治疗至少6个月。患者人口统计资料见表1。在HPN开始时,规定能量剂量为344 ~ 2805 kcal/d (6 ~ 45 kcal/kg/d),规定蛋白质剂量为35 ~ 190 g/d (0.6 ~ 2.1 g/kg/d)。在HPN的2周、2至3个月和6个月的间隔时间内,继续给予广泛的规定能量和蛋白质剂量。图1和图2为所有患者以及正在进食和不进食的患者提供了规定的能量和蛋白质剂量。对于不进食的患者,在PN治疗开始时,规定的能量范围为970至2791 kcal/d (8 kcal/kg/d至45 kcal/kg/d),蛋白质范围为40至190 g/d (0.6 g/kg/d至2.0 g/kg/d)。在每个研究间隔评估实际体重和目标体重之间的差异。在研究期间,患者的实际体重和目标体重之间的差异减小,表明达到目标体重有所改善(图3)。结论:本研究的结果表明,接受HPN的患者所规定的能量和蛋白质剂量范围很广。这不同于在住院患者中使用PN,在住院患者中,基于体重的宏量营养素目标往往更明确。在长期情况下,当患者口服摄入时,为了达到/维持目标体重,或为了改变基础疾病,常量营养素的调整可能是必要的。接受HPN的患者需要个性化的护理方法,可以由专门研究肠衰竭的跨学科营养支持团队提供。表1。6个月研究期
{"title":"Poster Abstracts","authors":"","doi":"10.1002/jpen.2735","DOIUrl":"10.1002/jpen.2735","url":null,"abstract":"&lt;p&gt;&lt;b&gt;P1–P34 Parenteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;P35–P52 Enteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;P53–P83 Malnutrition and Nutrition Assessment&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;P84–P103 Critical Care and Critical Health Issues&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;P104–P131 GI, Obesity, Metabolic, and Other Nutrition Related Concepts&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;P132–P165 Pediatric, Neonatal, Pregnancy, and Lactation&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Parenteral Nutrition Therapy&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Sarah Williams, MD, CNSC&lt;sup&gt;1&lt;/sup&gt;; Angela Zimmerman, RD, CNSC&lt;sup&gt;2&lt;/sup&gt;; Denise Jezerski, RD, CNSC&lt;sup&gt;2&lt;/sup&gt;; Ashley Bestgen, RD, CNSC&lt;sup&gt;2&lt;/sup&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Cleveland Clinic Foundation, Parma, OH; &lt;sup&gt;2&lt;/sup&gt;Cleveland Clinic Foundation, Cleveland, OH&lt;/p&gt;&lt;p&gt;&lt;b&gt;Financial Support:&lt;/b&gt; Morrison Healthcare.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Essential fatty acid deficiency (EFAD) is a rare disorder among the general population but can be a concern in patients reliant on home parenteral nutrition (HPN), particularly those who are not receiving intravenous lipid emulsions (ILE). In the US, the only ILE available until 2016 was soybean oil based (SO-ILE), which contains more than adequate amounts of essential fatty acids, including alpha-linolenic acid (ALA, an omega-3 fatty acid) and linoleic acid (LA, an omega-6 fatty acid). In 2016, a mixed ILE containing soybean oil, medium chain triglycerides, olive oil and fish oil, became available (SO, MCT, OO, FO-ILE). However, it contains a lower concentration of essential fatty acids compared to SO-ILE, raising theoretical concerns for development of EFAD if not administered in adequate amounts. Liver dysfunction is a common complication in HPN patients that can occur with soybean based ILE use due to their pro-inflammatory properties. Short-term studies and case reports in patients receiving SO, MCT, OO, FO-ILE have shown improvements in liver dysfunction for some patients. Our study evaluates the long-term impact of SO, MCT, OO, FO-ILE in our HPN patient population.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Methods:&lt;/b&gt; This single-center, retrospective cohort study was conducted at the Cleveland Clinic Center for Human Nutrition using data from 2017 to 2020. It involved adult patients who received HPN with SO, MCT, OO, FO-ILE for a minimum of one year. The study assessed changes in essential fatty acid profiles, including triene-tetraene ratios (TTRs) and liver function tests (LFTs) over the year. Data was described as mean and standard deviation for normal distributed continuous variables, medians and interquartile range for non-normally distributed continuous variables and frequency for categorical variables. The Wilcoxon signed rank test was used to compare the baseline and follow-up TTR values (mixed time points). The Wilcoxon signed rank test with pairwise comparisons was used to compare the LFTs at different time points and to determine which time groups were different. P-values were adjusted using Bonferroni corrections. Ordinal logistic regression was used to assess the association between lipid dosing and follow-up T","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 S1","pages":"S90-S308"},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2735","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024–2025 ASPEN Abstract Review Committee 2024-2025 ASPEN摘要审查委员会
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2736
<p>The American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee reviews, ranks and selects scientific and clinical practice abstracts submitted for presentation at the annual ASPEN Nutrition Science & Practice Conference. Members of this committee are experts in the field and have the necessary skills to review and evaluate submitted research abstracts, many of which are eligible for several prestigious abstract awards. Committee members may also serve as moderators in the oral paper sessions at the ASPEN Nutrition Science & Practice Conference. In compliance with accreditation standards, committee members complete conflicts of interest statements prior to participation and industry representatives and employees are not appointed to this committee.</p><p><b>The 2024–2025 ASPEN Abstract Review Committee</b></p><p><i>Co-Chairs</i>: April Church and Paul McCarthy</p><p><i>Parenteral Nutrition Therapy Group Leader:</i> Mireille Hamdan</p><p><i>Enteral Nutrition Therapy Group Leader:</i> Joy Douglas</p><p><i>Malnutrition and Nutrition Assessment Group Leader:</i> Jana Ponce</p><p><i>Critical Care and Critical Health Issues Group Leader:</i> Caran Graves</p><p><i>GI, Obesity, Metabolic, and Other Nutrition Related Concepts Group Leader:</i> Lindsey Russell</p><p><i>Pediatric, Neonatal, Pregnancy, and Lactation Group Leader:</i> Laura Gearman</p><p><i>ASPEN Board liaison to the committee: Anne Tucker</i></p><p><i>At-Large Committee Members:</i></p><p>Andrew Adorno</p><p>Monica Agarwal</p><p>Christine Allen</p><p>Mohammad Alsharhan</p><p>Leah Anderson</p><p>Stephanie Bachi De Castro Oliveira</p><p>Sarita Bajpai</p><p>Janice Baker</p><p>Lauren Beckman</p><p>Jonathan Berken</p><p>Miss Zainab Bibi</p><p>Barbara Bielawska</p><p>Ellen Bowser</p><p>Rebecca Brody</p><p>Cassandra Brown</p><p>Christopher Buckley</p><p>Lingtak-Neander Chan</p><p>Lee-anne Chapple</p><p>Anisha Chhibber</p><p>Adeeti Chiplunker</p><p>Vikram Christian</p><p>Laura Cutten</p><p>Valentina Da Prat</p><p>Emily Diemer</p><p>Felecia Dispense</p><p>Angela DiTucci</p><p>Jithinraj Edakkanambeth Varayil</p><p>Arlene Escuro</p><p>Gustave Falciglia</p><p>Kristy Feeney</p><p>Megan Follett</p><p>Amanda Gilhool</p><p>Allison Gomes</p><p>Shanna Hager</p><p>Benjamin Hall</p><p>Maria Hetherton</p><p>Jessie Hulst</p><p>Carol Ireton-Jones</p><p>Muna Islami</p><p>Syed-Mohammed Jafri</p><p>Renuka Jayatissa</p><p>Lisa Kinder</p><p>Merin Kinikini</p><p>Mark Klang</p><p>Samuel Kocoshis</p><p>Gabriela Lemos</p><p>Ada Lin</p><p>Rachel Ludke</p><p>Kristen MacEachern</p><p>Diana Mager</p><p>Abigail Martin</p><p>Christine Meissner</p><p>Yolanda Del Carmen Mendez</p><p>Lauri Metzger</p><p>Osman Mohamed Elfadil</p><p>Dawna Mughal</p><p>Samantha Mumford</p><p>Kristin Munroe</p><p>Michele Nicolo</p><p>Aimuan Oreavbiere</p><p>Hannah Piper</p><p>Jessica Pollard</p><p>Emily Ryder</p><p>William San Pablo</p><p>Senthilkumar Sankararaman</p><p>Christine Scarcello</p><p>Parul Sharma</p><p
美国肠外和肠内营养学会(ASPEN)摘要审查委员会对提交给年度ASPEN营养科学会议的科学和临床实践摘要进行审查、排序和选择。实践会议。该委员会的成员是该领域的专家,具有审查和评估提交的研究摘要的必要技能,其中许多有资格获得几个著名的摘要奖。委员会成员也可以在ASPEN营养科学会议的口头论文会议上担任主持人。实践会议。根据认证标准,委员会成员在参与前完成利益冲突声明,行业代表和雇员不被任命为委员会成员。2024-2025 ASPEN摘要审查委员会主席:April Church和Paul mccarthy肠外营养治疗组长:Mireille hamdan肠内营养治疗组长:Joy douglas营养不良和营养评估组长:Jana ponc重症监护和关键健康问题组长:Caran GravesGI、肥胖、代谢和其他营养相关概念组长:Lindsey russel儿科、新生儿、妊娠和哺乳期组长:Laura GearmanASPEN董事会委员会联络员:安妮·塔克特委员会成员:安德鲁·阿多诺莫尼卡·阿加瓦尔克里斯汀·艾伦·穆罕默德·阿尔夏罕·利亚·安德森斯蒂芬妮·巴奇·德·卡斯特罗奥利维拉·萨里塔·巴贾佩·珍妮丝·贝克·劳伦·贝克曼乔纳森·伯肯小姐扎纳布·比比芭芭拉·比拉劳斯卡·艾伦·鲍瑟丽贝卡·布罗迪·卡桑德拉·布朗克里斯托弗·巴克利·林克-尼安德德·钱利-安妮·查普利阿尼莎·奇布拉·迪埃蒂·奇普朗克维克拉姆·克里斯蒂安·劳拉·卡滕瓦伦蒂娜·达·普拉特艾米丽·迪默·菲莱西亚·迪斯宾·安吉拉·迪图奇·吉辛拉·埃达克卡纳贝斯·瓦拉伊娜·埃斯库罗·古斯塔夫falciglikristy FeeneyMegan FollettAmanda GilhoolAllison GomesShanna HagerBenjamin HallMaria HethertonJessie HulstCarol irton - jona muna IslamiSyed-Mohammed JafriRenuka JayatissaLisa KinderMerin kinikinkink samuel KocoshisGabriela LemosAda LinRachel LudkeKristen maceacherdiana MagerAbigail MartinChristine MeissnerYolanda Del MendezLauri MetzgerOsman Mohamed ElfadilDawna mugherm . michelle NicoloAimuan oreavbierhannah PiperJessica PollardEmily RyderWilliam圣·帕布洛斯·森蒂尔库马尔·桑卡拉玛曼克里斯汀·斯卡塞洛·帕鲁尔·莎玛玛莉萨·西卡洛·汤普森杰西卡·萨丽·蒂蒂娜·蒂诺科·奥乔娜·贾斯汀·特纳安德鲁·乌克莱贾·查安妮塔不开心的帕蒂洛·瓦尔德拉玛·帕帕罗·瓦斯孔塞洛·水晶·瓦斯奎拉·詹娜·韦尔奇南希·威廉·谢莉·威尔逊王春云·左小静
{"title":"2024–2025 ASPEN Abstract Review Committee","authors":"","doi":"10.1002/jpen.2736","DOIUrl":"10.1002/jpen.2736","url":null,"abstract":"&lt;p&gt;The American Society for Parenteral and Enteral Nutrition (ASPEN) Abstract Review Committee reviews, ranks and selects scientific and clinical practice abstracts submitted for presentation at the annual ASPEN Nutrition Science &amp; Practice Conference. Members of this committee are experts in the field and have the necessary skills to review and evaluate submitted research abstracts, many of which are eligible for several prestigious abstract awards. Committee members may also serve as moderators in the oral paper sessions at the ASPEN Nutrition Science &amp; Practice Conference. In compliance with accreditation standards, committee members complete conflicts of interest statements prior to participation and industry representatives and employees are not appointed to this committee.&lt;/p&gt;&lt;p&gt;&lt;b&gt;The 2024–2025 ASPEN Abstract Review Committee&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;Co-Chairs&lt;/i&gt;: April Church and Paul McCarthy&lt;/p&gt;&lt;p&gt;&lt;i&gt;Parenteral Nutrition Therapy Group Leader:&lt;/i&gt; Mireille Hamdan&lt;/p&gt;&lt;p&gt;&lt;i&gt;Enteral Nutrition Therapy Group Leader:&lt;/i&gt; Joy Douglas&lt;/p&gt;&lt;p&gt;&lt;i&gt;Malnutrition and Nutrition Assessment Group Leader:&lt;/i&gt; Jana Ponce&lt;/p&gt;&lt;p&gt;&lt;i&gt;Critical Care and Critical Health Issues Group Leader:&lt;/i&gt; Caran Graves&lt;/p&gt;&lt;p&gt;&lt;i&gt;GI, Obesity, Metabolic, and Other Nutrition Related Concepts Group Leader:&lt;/i&gt; Lindsey Russell&lt;/p&gt;&lt;p&gt;&lt;i&gt;Pediatric, Neonatal, Pregnancy, and Lactation Group Leader:&lt;/i&gt; Laura Gearman&lt;/p&gt;&lt;p&gt;&lt;i&gt;ASPEN Board liaison to the committee: Anne Tucker&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;At-Large Committee Members:&lt;/i&gt;&lt;/p&gt;&lt;p&gt;Andrew Adorno&lt;/p&gt;&lt;p&gt;Monica Agarwal&lt;/p&gt;&lt;p&gt;Christine Allen&lt;/p&gt;&lt;p&gt;Mohammad Alsharhan&lt;/p&gt;&lt;p&gt;Leah Anderson&lt;/p&gt;&lt;p&gt;Stephanie Bachi De Castro Oliveira&lt;/p&gt;&lt;p&gt;Sarita Bajpai&lt;/p&gt;&lt;p&gt;Janice Baker&lt;/p&gt;&lt;p&gt;Lauren Beckman&lt;/p&gt;&lt;p&gt;Jonathan Berken&lt;/p&gt;&lt;p&gt;Miss Zainab Bibi&lt;/p&gt;&lt;p&gt;Barbara Bielawska&lt;/p&gt;&lt;p&gt;Ellen Bowser&lt;/p&gt;&lt;p&gt;Rebecca Brody&lt;/p&gt;&lt;p&gt;Cassandra Brown&lt;/p&gt;&lt;p&gt;Christopher Buckley&lt;/p&gt;&lt;p&gt;Lingtak-Neander Chan&lt;/p&gt;&lt;p&gt;Lee-anne Chapple&lt;/p&gt;&lt;p&gt;Anisha Chhibber&lt;/p&gt;&lt;p&gt;Adeeti Chiplunker&lt;/p&gt;&lt;p&gt;Vikram Christian&lt;/p&gt;&lt;p&gt;Laura Cutten&lt;/p&gt;&lt;p&gt;Valentina Da Prat&lt;/p&gt;&lt;p&gt;Emily Diemer&lt;/p&gt;&lt;p&gt;Felecia Dispense&lt;/p&gt;&lt;p&gt;Angela DiTucci&lt;/p&gt;&lt;p&gt;Jithinraj Edakkanambeth Varayil&lt;/p&gt;&lt;p&gt;Arlene Escuro&lt;/p&gt;&lt;p&gt;Gustave Falciglia&lt;/p&gt;&lt;p&gt;Kristy Feeney&lt;/p&gt;&lt;p&gt;Megan Follett&lt;/p&gt;&lt;p&gt;Amanda Gilhool&lt;/p&gt;&lt;p&gt;Allison Gomes&lt;/p&gt;&lt;p&gt;Shanna Hager&lt;/p&gt;&lt;p&gt;Benjamin Hall&lt;/p&gt;&lt;p&gt;Maria Hetherton&lt;/p&gt;&lt;p&gt;Jessie Hulst&lt;/p&gt;&lt;p&gt;Carol Ireton-Jones&lt;/p&gt;&lt;p&gt;Muna Islami&lt;/p&gt;&lt;p&gt;Syed-Mohammed Jafri&lt;/p&gt;&lt;p&gt;Renuka Jayatissa&lt;/p&gt;&lt;p&gt;Lisa Kinder&lt;/p&gt;&lt;p&gt;Merin Kinikini&lt;/p&gt;&lt;p&gt;Mark Klang&lt;/p&gt;&lt;p&gt;Samuel Kocoshis&lt;/p&gt;&lt;p&gt;Gabriela Lemos&lt;/p&gt;&lt;p&gt;Ada Lin&lt;/p&gt;&lt;p&gt;Rachel Ludke&lt;/p&gt;&lt;p&gt;Kristen MacEachern&lt;/p&gt;&lt;p&gt;Diana Mager&lt;/p&gt;&lt;p&gt;Abigail Martin&lt;/p&gt;&lt;p&gt;Christine Meissner&lt;/p&gt;&lt;p&gt;Yolanda Del Carmen Mendez&lt;/p&gt;&lt;p&gt;Lauri Metzger&lt;/p&gt;&lt;p&gt;Osman Mohamed Elfadil&lt;/p&gt;&lt;p&gt;Dawna Mughal&lt;/p&gt;&lt;p&gt;Samantha Mumford&lt;/p&gt;&lt;p&gt;Kristin Munroe&lt;/p&gt;&lt;p&gt;Michele Nicolo&lt;/p&gt;&lt;p&gt;Aimuan Oreavbiere&lt;/p&gt;&lt;p&gt;Hannah Piper&lt;/p&gt;&lt;p&gt;Jessica Pollard&lt;/p&gt;&lt;p&gt;Emily Ryder&lt;/p&gt;&lt;p&gt;William San Pablo&lt;/p&gt;&lt;p&gt;Senthilkumar Sankararaman&lt;/p&gt;&lt;p&gt;Christine Scarcello&lt;/p&gt;&lt;p&gt;Parul Sharma&lt;/p&gt;&lt;p","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 S1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2736","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143689050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harry M. Vars Award Candidate Abstracts Harry M. Vars奖候选人摘要。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2734
<p>Monday, March 24, 2025</p><p>Premier Paper Session and Vars Award Competition</p><p><b>Harry M. Vars Award Candidate</b></p><p>Lizl Veldsman, RD, M Nutr, BSc Dietetics<sup>1</sup>; Guy Richards, MD, PhD<sup>2</sup>; Daniel Nel, PhD<sup>3</sup>; Renée Blaauw, PhD, RD<sup>1</sup></p><p><sup>1</sup>Division of Human Nutrition, Department of Global Health, Faculty of Medicine & Health Sciences, Stellenbosch University, Cape Town, Western Cape; <sup>2</sup>Department of Surgery, Division of Critical Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng; <sup>3</sup>Centre for Statistical Consultation, Department of Statistics and Actuarial Science, Stellenbosch University, Stellenbosch, Western Cape</p><p><b>Financial Support:</b> This research study was funded by the Fresenius Kabi Jumpstart Research grant.</p><p><b>Background:</b> Critical illness is associated with severe muscle wasting. A combination of protein supplementation and mobilization may attenuate muscle loss. We determined the effect of a combination of intravenous (IV) bolus amino acid (AA) supplementation and in-bed cycling, versus standard care only, on skeletal muscle mass during the first ICU week.</p><p><b>Methods:</b> This randomized controlled trial (ClinicalTrials.gov NCT04099108) was undertaken in a predominantly trauma adult surgical ICU. Participants were randomly assigned into two groups, both of which received standard care nutrition (SCN) and mobilization. The intervention group received an additional IV AA bolus, starting on ICU day 3 on-average, along with a 45-minute in-bed cycling session for a mean of 6 days. Histological change in vastus lateralis (VL) myofiber cross-sectional area (CSA) and ultrasound rectus femoris (RF) muscle CSA was measured from pre-intervention (average ICU day 2) to post-intervention (average ICU day 8) and analyzed using mixed model ANOVA and post hoc least significant difference (LSD) testing. Secondarily, we assessed the change in the protein-to-DNA ratio over time. We further compared responses between participants with and without baseline organ dysfunction (defined as SOFA≥2, due to infection or trauma-related inflammation).</p><p><b>Results:</b> Fifty critically ill patients (90% male, mean age 37±12 years, APACHE II score 13.5±6.6, SOFA score 4.5±3.2, BMI 24.8±4.0 kg/m<sup>2</sup>, modified NUTRIC 2.2±1.8) were included. The control (n = 25) and intervention (n = 25) groups received, on average, 87.62±32.18 and 85.53±29.29 grams of protein per day (1.26±0.41 and 1.29±0.40g/kg/day, respectively) from SCN, and the intervention group an additional 30.43±5.62 grams of AA (0.37±0.06g/kg protein equivalents) from the supplement. There was significant loss of muscle mass over time in all participants (VL myofiber CSA 11.76%, p = 0.011; RF muscle CSA 13.01% p < 0.001). No significant difference was found between groups, but a more compatible trend for greater muscle loss in the control group versus
2025年3月24日,星期一,主要论文会议和Vars奖竞赛harry M. Vars奖候选人elizl Veldsman, RD, M nur, BSc dietetic1;Guy Richards, MD, PhD2;Daniel Nel博士;ren<s:1> e Blaauw,博士,医学学院全球健康系人类营养研究室;西开普省开普敦斯泰伦博斯大学健康科学系;2约翰内斯堡,豪登省威特沃特斯兰德大学健康科学学院重症监护科外科;3 Stellenbosch大学统计与精算科学系统计咨询中心,Stellenbosch,西开普省Stellenbosch。财政支持:本研究由Fresenius Kabi Jumpstart research基金资助。背景:危重症与严重的肌肉萎缩有关。补充蛋白质和运动相结合可以减轻肌肉损失。我们确定了静脉注射(IV)氨基酸(AA)补充和床上循环相结合,与标准护理相比,在ICU第一周对骨骼肌质量的影响。方法:该随机对照试验(ClinicalTrials.gov NCT04099108)在主要为创伤的成人外科ICU进行。参与者被随机分为两组,两组均接受标准护理营养(SCN)和动员。干预组平均在ICU第3天开始接受额外的静脉注射AA,同时进行45分钟的床上骑行,平均持续6天。从干预前(平均ICU第2天)到干预后(平均ICU第8天)测量股外侧肌(VL)肌纤维横截面积(CSA)和超声股直肌(RF)肌肉CSA的组织学变化,并采用混合模型方差分析和事后最小显著性差异(LSD)检验进行分析。其次,我们评估了蛋白质与dna比率随时间的变化。我们进一步比较了有和没有基线器官功能障碍(定义为SOFA≥2,由于感染或创伤相关炎症)的参与者之间的反应。结果:纳入危重患者50例(男性90%,平均年龄37±12岁,APACHEⅱ评分13.5±6.6,SOFA评分4.5±3.2,BMI 24.8±4.0 kg/m2,改良NUTRIC评分2.2±1.8)。对照组(n = 25)和干预组(n = 25)平均每天从SCN中获得87.62±32.18和85.53±29.29 g蛋白质(分别为1.26±0.41和1.29±0.40g/kg/d),干预组从补充物中额外获得30.43±5.62 g AA(0.37±0.06g/kg蛋白质当量)。随着时间的推移,所有参与者的肌肉质量都显著下降(VL肌纤维CSA 11.76%, p = 0.011;RF肌CSA 13.01% p &lt; 0.001)。两组间无显著差异,但对照组与干预组相比有更大的肌肉损失趋势(p = 0.051 vs p = 0.067)(表1)。随着时间的推移,蛋白质与dna比率显著上升(p = 0.007),但仅在干预组显著(对照组11.33%,p = 0.177;干预20.96%,p = 0.007)(表1)。调整基线器官功能障碍的混合模型方差分析显示研究组效应显著(p = 0.012)。事后LSD比较显示,在没有基线器官功能障碍的参与者中,对照组的VL肌纤维CSA损失明显更大(前:3803.19 vs后:2845.60,p = 0.034),而干预组未观察到显著损失(前:4580.19 vs后:4393.86,p = 0.787)。结论:患者在ICU的第一周出现明显的肌肉量损失。虽然对照组和干预组之间没有显著差异,但干预组的蛋白质与dna比率显著增加,表明对肌肉蛋白质含量有潜在的益处。此外,我们的研究结果表明,在没有基线器官功能障碍的患者中,干预可能更有效。未来的研究应将干预延长至第一个ICU周之后,以评估更长的干预时间是否能改善肌肉CSA并增强肌肉保存。表1。干预前后股外侧肌纤维横截面积(CSA)、股直肌CSA和蛋白- dna比值的变化。哈利·瓦尔斯奖候选人加布里埃拉·德·奥利维拉·莱莫斯,MD1;娜塔莎·门东帕拉·马查多博士;Raquel Torrinhas博士;Dan Linetzky Waitzberg,博士31圣保罗大学医学院,Brasília,联邦区;2巴西圣保罗大学医学院,巴西圣保罗;3巴西<s:1>圣保罗大学医学院,巴西圣保罗<e:1>财政支持:本研究与项目编号:2011/09612-3,由<s:1>圣保罗州研究支持基金会(FAPESP)资助。背景:鞘脂(Sphingolipids, SLs)有助于真核生物细胞膜的结构完整性,并在细胞调控的信号通路中发挥中介作用。 脂质分子(包括SLs)的积累可导致脂肪毒性、代谢失调、胰岛素抵抗和代谢疾病。本研究旨在评估肥胖和2型糖尿病(T2DM)女性患者Roux-en-Y胃旁路手术(RYGB)后血浆SLs与葡萄糖和胆固醇代谢生化指标以及体成分之间的关系。该调查是SURMetaGIT研究的一部分,注册于www.clinicalTrials.gov (NCT01251016)。方法:30例II-III级肥胖和2型糖尿病患者接受RYGB治疗。在基线和术后3个月进行评估。胰岛素治疗患者排除在外。对血浆样本进行生化(n=30)和代谢组学(n=28)分析。评估体重(kg)、身体成分(空气置换体积脉搏图)和人体测量指标。通过液相色谱-质谱联用的非靶向代谢组学分析鉴定了SLs。使用AnalysisBaseFileConverter和MS-DIAL进行数据处理和分析。采用Jamovi软件(2.2.5)和MetaboAnalyst 5.0进行统计。通过术后平均值/术前平均值的log2计算Fold change。组间比较采用配对t检验,采用正态性检验。相关性分析采用Spearman检验。α误差&lt; 0.05认为结果显著。结果:RYGB治疗后,患者体重、BMI、腰围、臀围均明显降低(图1)。患者在糖代谢方面有代谢改善:空腹血糖(215.8±72.4 vs 104±21.7 mg/dL),胰岛素(21.6±14.7 vs 11.1±9.2),糖化血红蛋白(8.9±1.6 vs 6.04±0.5),c肽(4.02±1.3 vs 2.9±0.8)- p&lt; .001)。总胆固醇降低(192±30.7 vs 149.5±29.2 mg/dL, p = 0.004),以导致动脉粥样硬化的部分为代价:非hdl -c(143±35.5 vs 107±42 mg/dL, p = 0.001), LDL-c(114±29.5 vs 88.5±30.2 mg/dL, p = 0.01), VLDL-c(29.5±15 vs 21±7 mg/dL, p = 0.002), TG(150±85.2 vs 104.5±36.7 mg/dL, p = 0.004)。图2显示了RYGB前后SLs的热图。在34个确定的SLs中,有21个在手术后发生了显著变化(图3)。Cer (d18:1/23:0)和Cer (d42:1)与人体测量值和体脂呈中度负相关,但与瘦质量呈正相关。另一方面,SM (d38:2)表现出相反的效果。葡萄糖代谢生化指标与SLs之间的相关性较差,然而,这些变量与胆固醇及其组分之间表现出强烈而稳健的相关性,特别是在RYGB之后(表1)。结论:与RYGB
{"title":"Harry M. Vars Award Candidate Abstracts","authors":"","doi":"10.1002/jpen.2734","DOIUrl":"10.1002/jpen.2734","url":null,"abstract":"&lt;p&gt;Monday, March 24, 2025&lt;/p&gt;&lt;p&gt;Premier Paper Session and Vars Award Competition&lt;/p&gt;&lt;p&gt;&lt;b&gt;Harry M. Vars Award Candidate&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Lizl Veldsman, RD, M Nutr, BSc Dietetics&lt;sup&gt;1&lt;/sup&gt;; Guy Richards, MD, PhD&lt;sup&gt;2&lt;/sup&gt;; Daniel Nel, PhD&lt;sup&gt;3&lt;/sup&gt;; Renée Blaauw, PhD, RD&lt;sup&gt;1&lt;/sup&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Division of Human Nutrition, Department of Global Health, Faculty of Medicine &amp; Health Sciences, Stellenbosch University, Cape Town, Western Cape; &lt;sup&gt;2&lt;/sup&gt;Department of Surgery, Division of Critical Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng; &lt;sup&gt;3&lt;/sup&gt;Centre for Statistical Consultation, Department of Statistics and Actuarial Science, Stellenbosch University, Stellenbosch, Western Cape&lt;/p&gt;&lt;p&gt;&lt;b&gt;Financial Support:&lt;/b&gt; This research study was funded by the Fresenius Kabi Jumpstart Research grant.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Background:&lt;/b&gt; Critical illness is associated with severe muscle wasting. A combination of protein supplementation and mobilization may attenuate muscle loss. We determined the effect of a combination of intravenous (IV) bolus amino acid (AA) supplementation and in-bed cycling, versus standard care only, on skeletal muscle mass during the first ICU week.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Methods:&lt;/b&gt; This randomized controlled trial (ClinicalTrials.gov NCT04099108) was undertaken in a predominantly trauma adult surgical ICU. Participants were randomly assigned into two groups, both of which received standard care nutrition (SCN) and mobilization. The intervention group received an additional IV AA bolus, starting on ICU day 3 on-average, along with a 45-minute in-bed cycling session for a mean of 6 days. Histological change in vastus lateralis (VL) myofiber cross-sectional area (CSA) and ultrasound rectus femoris (RF) muscle CSA was measured from pre-intervention (average ICU day 2) to post-intervention (average ICU day 8) and analyzed using mixed model ANOVA and post hoc least significant difference (LSD) testing. Secondarily, we assessed the change in the protein-to-DNA ratio over time. We further compared responses between participants with and without baseline organ dysfunction (defined as SOFA≥2, due to infection or trauma-related inflammation).&lt;/p&gt;&lt;p&gt;&lt;b&gt;Results:&lt;/b&gt; Fifty critically ill patients (90% male, mean age 37±12 years, APACHE II score 13.5±6.6, SOFA score 4.5±3.2, BMI 24.8±4.0 kg/m&lt;sup&gt;2&lt;/sup&gt;, modified NUTRIC 2.2±1.8) were included. The control (n = 25) and intervention (n = 25) groups received, on average, 87.62±32.18 and 85.53±29.29 grams of protein per day (1.26±0.41 and 1.29±0.40g/kg/day, respectively) from SCN, and the intervention group an additional 30.43±5.62 grams of AA (0.37±0.06g/kg protein equivalents) from the supplement. There was significant loss of muscle mass over time in all participants (VL myofiber CSA 11.76%, p = 0.011; RF muscle CSA 13.01% p &lt; 0.001). No significant difference was found between groups, but a more compatible trend for greater muscle loss in the control group versus","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 S1","pages":"S81-S89"},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2734","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction to Conference Abstracts 会议摘要简介。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-19 DOI: 10.1002/jpen.2731

The American Society for Parenteral and Enteral Nutrition (ASPEN) is dedicated to improving patient care by advancing the science and practice of clinical nutrition and metabolism. Founded in 1975, ASPEN is an interprofessional organization whose members are involved in the provision of clinical nutrition therapies, including parenteral and enteral nutrition. With more than 6000 members from around the world, ASPEN is a community of dietitians, nurses, pharmacists, physicians, scientists, students, and other health professionals from every facet of nutrition support clinical practice, research, and education.

ASPEN hosts an annual forum for clinical nutrition research and education, the ASPEN Nutrition Science & Practice Conference. The ASPEN Abstract Review Committee reviewed all abstracts submitted for the conference and selected those published herein for presentation. Selected abstracts feature data relevant to nutrition therapy and metabolic support, many of which were eligible for several of ASPEN's prestigious abstract awards.

The abstracts in this supplement have not been copyedited. Any errors contained within the abstracts are the sole responsibility of the authors. ASPEN does not assume liability for any errors herein. This content does not constitute medical or other professional advice. Please visit ASPEN's conference webpage for more information: https://www.nutritioncare.org/conference/

美国肠外和肠内营养学会(ASPEN)致力于通过推进临床营养和代谢的科学和实践来改善患者护理。ASPEN成立于1975年,是一个跨专业组织,其成员参与提供临床营养治疗,包括肠外和肠内营养。ASPEN拥有来自世界各地的6000多名会员,是一个由营养师、护士、药剂师、医生、科学家、学生和其他健康专业人士组成的社区,他们来自营养支持临床实践、研究和教育的各个方面。ASPEN每年举办一次临床营养研究和教育论坛,即ASPEN营养科学与教育论坛。实践会议。ASPEN摘要审查委员会审查了提交给会议的所有摘要,并选择在此发表的摘要进行展示。选定的摘要具有与营养治疗和代谢支持相关的数据,其中许多有资格获得ASPEN的几个著名的摘要奖。本增刊中的摘要未经过编辑。摘要中包含的任何错误是作者的唯一责任。ASPEN不对任何错误承担责任。此内容不构成医疗或其他专业建议。请访问ASPEN的会议网页获取更多信息:https://www.nutritioncare.org/conference/
{"title":"Introduction to Conference Abstracts","authors":"","doi":"10.1002/jpen.2731","DOIUrl":"10.1002/jpen.2731","url":null,"abstract":"<p>The American Society for Parenteral and Enteral Nutrition (ASPEN) is dedicated to improving patient care by advancing the science and practice of clinical nutrition and metabolism. Founded in 1975, ASPEN is an interprofessional organization whose members are involved in the provision of clinical nutrition therapies, including parenteral and enteral nutrition. With more than 6000 members from around the world, ASPEN is a community of dietitians, nurses, pharmacists, physicians, scientists, students, and other health professionals from every facet of nutrition support clinical practice, research, and education.</p><p>ASPEN hosts an annual forum for clinical nutrition research and education, the ASPEN Nutrition Science &amp; Practice Conference. The ASPEN Abstract Review Committee reviewed all abstracts submitted for the conference and selected those published herein for presentation. Selected abstracts feature data relevant to nutrition therapy and metabolic support, many of which were eligible for several of ASPEN's prestigious abstract awards.</p><p>The abstracts in this supplement have not been copyedited. Any errors contained within the abstracts are the sole responsibility of the authors. ASPEN does not assume liability for any errors herein. This content does not constitute medical or other professional advice. Please visit ASPEN's conference webpage for more information: https://www.nutritioncare.org/conference/</p>","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 S1","pages":""},"PeriodicalIF":4.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2731","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143663502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study 接受家庭肠外营养的成年慢性肠衰竭患者肠衰竭相关肝病:一项描述性队列研究
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-16 DOI: 10.1002/jpen.2746
Sarah Frezet MD, Paul Hermabessière MD, Laurianne Kerlogot RD, Eva Wilsius RN, Coraline Balde RN, Gauthier Pellet MD, Constance Chevrier PharmD, Jean Castinel MD, Victor de Ledinghen MD, PhD, Florian Poullenot MD

Background

Intestinal failure–associated liver disease (IFALD) is a major complication of chronic intestinal failure. Few data exist about hepatic monitoring of IFALD using the liver stiffness measurement. The aim of this study was to provide a descriptive analysis of IFALD and its prevalence in a tertiary center and to determine the IFALD risk factors and high liver stiffness measurement values using FibroScan.

Methods

Adult patients with chronic intestinal failure treated with home parenteral nutrition and followed in a tertiary center with no underlying liver disease and at least one liver stiffness measurement record were included between January 1, 2007, and June 6, 2023.

Results

Eighty-nine patients were included from this cohort of 145 patients. The prevalence of IFALD was 34%. A total of 14% had a liver stiffness measurement >10 kPa, and 49% had a liver stiffness measurement <5 kPa. In multivariate analysis, IFALD was positively associated with the use of a customized admixture (odds ratio [OR] = 7.04; 95% CI, 1.44–43.64; P = 0.017) and negatively associated with the colon in continuity (OR = 0.25; 95% CI, 0.07–0.87; P = 0.029). No significant association was observed between liver stiffness measurement values and IFALD.

Conclusion

The prevalence of IFALD was low in our study. Absence of the colon and the use of a customized admixture were risk factors for IFALD. Liver stiffness measurement was abnormal in 51% of cases. A long-term follow-up of this cohort will help to assess the prognostic relevance of IFALD and liver stiffness measurement in these patients.

背景:肠功能衰竭相关性肝病(IFALD)是慢性肠功能衰竭的主要并发症。使用肝脏硬度测量法对 IFALD 进行肝脏监测的数据很少。本研究旨在对一家三级医院的 IFALD 及其发病率进行描述性分析,并使用 FibroScan 确定 IFALD 的风险因素和肝脏僵硬度测量值:方法:纳入2007年1月1日至2023年6月6日期间在一家三级中心接受家庭肠外营养治疗的慢性肠功能衰竭成人患者,这些患者没有潜在的肝脏疾病,且至少有一次肝脏硬度测量记录:共有 145 名患者,其中包括 89 名患者。IFALD的发病率为34%。共有 14% 的患者肝脏硬度测量值大于 10 kPa,49% 的患者肝脏硬度测量值小于 10 kPa:在我们的研究中,IFALD 的发病率较低。无结肠和使用定制的混合物是导致 IFALD 的风险因素。51%的病例肝脏硬度测量结果异常。对这批患者进行长期随访将有助于评估 IFALD 和肝硬度测量对这些患者预后的相关性。
{"title":"Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study","authors":"Sarah Frezet MD,&nbsp;Paul Hermabessière MD,&nbsp;Laurianne Kerlogot RD,&nbsp;Eva Wilsius RN,&nbsp;Coraline Balde RN,&nbsp;Gauthier Pellet MD,&nbsp;Constance Chevrier PharmD,&nbsp;Jean Castinel MD,&nbsp;Victor de Ledinghen MD, PhD,&nbsp;Florian Poullenot MD","doi":"10.1002/jpen.2746","DOIUrl":"10.1002/jpen.2746","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Intestinal failure–associated liver disease (IFALD) is a major complication of chronic intestinal failure. Few data exist about hepatic monitoring of IFALD using the liver stiffness measurement. The aim of this study was to provide a descriptive analysis of IFALD and its prevalence in a tertiary center and to determine the IFALD risk factors and high liver stiffness measurement values using FibroScan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Adult patients with chronic intestinal failure treated with home parenteral nutrition and followed in a tertiary center with no underlying liver disease and at least one liver stiffness measurement record were included between January 1, 2007, and June 6, 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Eighty-nine patients were included from this cohort of 145 patients. The prevalence of IFALD was 34%. A total of 14% had a liver stiffness measurement &gt;10 kPa, and 49% had a liver stiffness measurement &lt;5 kPa. In multivariate analysis, IFALD was positively associated with the use of a customized admixture (odds ratio [OR] = 7.04; 95% CI, 1.44–43.64; <i>P</i> = 0.017) and negatively associated with the colon in continuity (OR = 0.25; 95% CI, 0.07–0.87; <i>P</i> = 0.029). No significant association was observed between liver stiffness measurement values and IFALD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The prevalence of IFALD was low in our study. Absence of the colon and the use of a customized admixture were risk factors for IFALD. Liver stiffness measurement was abnormal in 51% of cases. A long-term follow-up of this cohort will help to assess the prognostic relevance of IFALD and liver stiffness measurement in these patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 4","pages":"507-516"},"PeriodicalIF":4.1,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jpen.2746","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measured resting energy expenditure and predicted resting energy expenditure based on ASPEN critical care guidelines for nutrition support: An agreement study 基于ASPEN重症监护营养支持指南测量静息能量消耗和预测静息能量消耗:一项协议研究。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-12 DOI: 10.1002/jpen.2744
Kiara Gaspari MND, Jessica Flechner-Klein MND, Tamara R. Cohen PhD, RD, Courtney Wedemire DCN, RD

Background

Predictive equations often inaccurately estimate energy needs in critically ill patients. This study evaluated the level of agreement between resting energy expenditure using 12 and 25 kcal/kg as recommended by the 2021 American Society for Parenteral and Enteral Nutrition critical care guidelines for nutrition support and energy expenditure measured by indirect calorimetry in patients in the intensive care unit.

Methods

An agreement study was conducted on mechanically ventilated adults who had a documented measured energy expenditure within 10 days of intensive care unit admission. Agreement was assessed using Bland-Altman plots and Wilcoxon signed rank tests. A subgroup analysis was performed for patients with a body mass index of ≥30 kg/m² using actual body weight, adjusted body weight, and ideal body weight. Correlations between measured energy expenditure and patient characteristics were also explored.

Results

Fifty-eight patients were included and were a median age of 64 years, 63.8% male, and a median body mass index of 28.0 kg/m2. The 12 kcal/kg and 25 kcal/kg differed significantly from measured energy expenditure (P < 0.001). Bland-Altman plots showed mean biases of −644.6 kcal/day for 12 kcal/kg and 406.5 kcal/day for 25 kcal/kg. In the body mass index ≥30 kg/m² subgroup (n = 22), 12 kcal/kg underestimated measured energy expenditure across all weights, and 25 kcal/kg was more accurate when using ideal or adjusted body weights.

Conclusions

Predicted energy expenditure using 12 kcal/kg and 25 kcal/kg based on the 2021 American Society for Parenteral and Enteral Nutrition critical care guidelines for nutrition support had poor agreement with measured energy expenditure in mechanically ventilated patients.

背景:预测方程往往不能准确地估计危重病人的能量需求。本研究评估了2021年美国肠外和肠内营养学会重症监护指南中推荐的12和25千卡/千克静息能量消耗与间接量热法测量重症监护病房患者营养支持和能量消耗之间的一致程度。方法:一项协议研究对机械通气的成年人进行了研究,这些成年人在重症监护病房入院10天内记录了测量的能量消耗。一致性评估采用Bland-Altman图和Wilcoxon签署秩检验。采用实际体重、调整体重和理想体重对体重指数≥30 kg/m²的患者进行亚组分析。测量的能量消耗与患者特征之间的相关性也进行了探讨。结果:纳入患者58例,中位年龄64岁,男性占63.8%,中位体重指数28.0 kg/m2。12 kcal/kg和25 kcal/kg与测量的能量消耗有显著差异(P结论:根据2021年美国肠外和肠内营养学会营养支持重症监护指南,使用12 kcal/kg和25 kcal/kg预测的能量消耗与机械通气患者测量的能量消耗不一致。
{"title":"Measured resting energy expenditure and predicted resting energy expenditure based on ASPEN critical care guidelines for nutrition support: An agreement study","authors":"Kiara Gaspari MND,&nbsp;Jessica Flechner-Klein MND,&nbsp;Tamara R. Cohen PhD, RD,&nbsp;Courtney Wedemire DCN, RD","doi":"10.1002/jpen.2744","DOIUrl":"10.1002/jpen.2744","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Predictive equations often inaccurately estimate energy needs in critically ill patients. This study evaluated the level of agreement between resting energy expenditure using 12 and 25 kcal/kg as recommended by the 2021 American Society for Parenteral and Enteral Nutrition critical care guidelines for nutrition support and energy expenditure measured by indirect calorimetry in patients in the intensive care unit.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An agreement study was conducted on mechanically ventilated adults who had a documented measured energy expenditure within 10 days of intensive care unit admission. Agreement was assessed using Bland-Altman plots and Wilcoxon signed rank tests. A subgroup analysis was performed for patients with a body mass index of ≥30 kg/m² using actual body weight, adjusted body weight, and ideal body weight. Correlations between measured energy expenditure and patient characteristics were also explored.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Fifty-eight patients were included and were a median age of 64 years, 63.8% male, and a median body mass index of 28.0 kg/m<sup>2</sup>. The 12 kcal/kg and 25 kcal/kg differed significantly from measured energy expenditure (<i>P</i> &lt; 0.001). Bland-Altman plots showed mean biases of −644.6 kcal/day for 12 kcal/kg and 406.5 kcal/day for 25 kcal/kg. In the body mass index ≥30 kg/m² subgroup (<i>n</i> = 22), 12 kcal/kg underestimated measured energy expenditure across all weights, and 25 kcal/kg was more accurate when using ideal or adjusted body weights.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Predicted energy expenditure using 12 kcal/kg and 25 kcal/kg based on the 2021 American Society for Parenteral and Enteral Nutrition critical care guidelines for nutrition support had poor agreement with measured energy expenditure in mechanically ventilated patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 4","pages":"468-475"},"PeriodicalIF":4.1,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indirect calorimetry in traumatically injured patients: A descriptive cohort study 创伤性损伤患者的间接量热法:一项描述性队列研究。
IF 4.1 3区 医学 Q2 NUTRITION & DIETETICS Pub Date : 2025-03-12 DOI: 10.1002/jpen.2745
Stacy Pelekhaty MS, RD, Karina Rozenberg RN, Rosemary Kozar MD, PhD

Background

Trauma patients have historically been considered profoundly hypermetabolic. The purpose of this study was to describe energy expenditure using indirect calorimetry and to compare indirect calorimetry to predictive equations in trauma patients.

Methods

Indirect calorimetry was performed using a Q-NRG+ by a trained dietitian nutritionist. Results were obtained in mechanically ventilated trauma patients between September 2023 and June 2024. Demographic data, injury characteristics, and outcomes were collected. Results were compared with energy expenditure predicted with 20, 25, and 30 kcal/kg; Penn State 2003b; and Schofield in adolescents on the day of indirect calorimetry using the Wilcoxon test. Subanalysis was completed in adolescents and older adults. Energy expenditure was evaluated over time.

Results

A total of 164 indirect calorimetry results from 117 patients were analyzed. Among participants, median age was 43 (28–62) years, 85% were with blunt mechanism of injury, and and 80% were male. Median energy expenditure was 1869 kcal/day (1618–2265 kcal/day). In the full cohort, 20 kcal/kg underestimated energy needs, whereas other equations overestimated needs. In adolescents, 25 kcal/kg and Schofield were not significantly different than indirect calorimetry (P = 0.15 and 0.64). In older adults, 20 kcal/kg was not significantly different from indirect calorimetry (P = 0.58). A weak association was observed between prescribed and measured energy (r = 0.32, P < 0.001).

Conclusion

Predictive equations recommended in critical care do not accurately reflect energy expenditure in trauma patients. Indirect calorimetry remains the preferred method for determining energy needs and the availability of the bedside dietitian nutritionist to perform these assessments facilitates timely, serial testing.

背景:创伤患者历来被认为是严重的高代谢。本研究的目的是用间接量热法描述创伤患者的能量消耗,并将间接量热法与预测方程进行比较。方法:由训练有素的营养学家使用Q-NRG+进行间接量热。结果为2023年9月至2024年6月机械通气创伤患者。收集了人口统计数据、损伤特征和结果。将预测的能量消耗与20、25和30 kcal/kg进行比较;宾夕法尼亚州立大学2003b;和Schofield在使用Wilcoxon测试的间接量热当天。在青少年和老年人中完成了亚分析。随着时间的推移评估能量消耗。结果:对117例患者的164份间接量热结果进行了分析。参与者中位年龄为43岁(28-62岁),85%为钝性损伤,80%为男性。平均能量消耗为1869千卡/天(1618-2265千卡/天)。在整个队列中,20千卡/公斤低估了能量需求,而其他方程高估了能量需求。青少年25 kcal/kg和Schofield量热法与间接量热法比较差异无统计学意义(P = 0.15和0.64)。在老年人中,20 kcal/kg与间接量热法无显著差异(P = 0.58)。处方能量和测量能量之间存在弱相关性(r = 0.32, P)。结论:在重症监护中推荐的预测方程不能准确反映创伤患者的能量消耗。间接量热法仍然是确定能量需求的首选方法,床边营养学家执行这些评估的可用性有助于及时、连续的测试。
{"title":"Indirect calorimetry in traumatically injured patients: A descriptive cohort study","authors":"Stacy Pelekhaty MS, RD,&nbsp;Karina Rozenberg RN,&nbsp;Rosemary Kozar MD, PhD","doi":"10.1002/jpen.2745","DOIUrl":"10.1002/jpen.2745","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Trauma patients have historically been considered profoundly hypermetabolic. The purpose of this study was to describe energy expenditure using indirect calorimetry and to compare indirect calorimetry to predictive equations in trauma patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Indirect calorimetry was performed using a Q-NRG+ by a trained dietitian nutritionist. Results were obtained in mechanically ventilated trauma patients between September 2023 and June 2024. Demographic data, injury characteristics, and outcomes were collected. Results were compared with energy expenditure predicted with 20, 25, and 30 kcal/kg; Penn State 2003b; and Schofield in adolescents on the day of indirect calorimetry using the Wilcoxon test. Subanalysis was completed in adolescents and older adults. Energy expenditure was evaluated over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 164 indirect calorimetry results from 117 patients were analyzed. Among participants, median age was 43 (28–62) years, 85% were with blunt mechanism of injury, and and 80% were male. Median energy expenditure was 1869 kcal/day (1618–2265 kcal/day). In the full cohort, 20 kcal/kg underestimated energy needs, whereas other equations overestimated needs. In adolescents, 25 kcal/kg and Schofield were not significantly different than indirect calorimetry (<i>P</i> = 0.15 and 0.64). In older adults, 20 kcal/kg was not significantly different from indirect calorimetry (<i>P</i> = 0.58). A weak association was observed between prescribed and measured energy (<i>r</i> = 0.32, <i>P</i> &lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Predictive equations recommended in critical care do not accurately reflect energy expenditure in trauma patients. Indirect calorimetry remains the preferred method for determining energy needs and the availability of the bedside dietitian nutritionist to perform these assessments facilitates timely, serial testing.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16668,"journal":{"name":"Journal of Parenteral and Enteral Nutrition","volume":"49 4","pages":"488-496"},"PeriodicalIF":4.1,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Parenteral and Enteral Nutrition
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1